New clinical trial data show an extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder.
[print-me /]
[print-me /]
New clinical trial data show an extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder.